Clinical trials recruiting in Winnenden, Germany

Phase breakdown

Conditions recruiting in Winnenden, Germany

Recruiting trials in Winnenden, Germany

• A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
  NCT06830720 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
• Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
  NCT05452213 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female
• Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
  NCT05512364 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer
  NCT06201234 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• NeoRad Breast Cancer Study
  NCT04261244 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female
• Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®
  NCT05114850 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Winnenden, Germany?

6 recruiting trials have at least one study site in Winnenden, Germany.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.